Literature DB >> 6306028

High-performance liquid chromatographic determination of cefmenoxime (AB-50912) in human plasma and urine.

I A Noonan, J G Gambertoglio, S L Barriere, J E Conte, E T Lin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6306028     DOI： 10.1016/s0378-4347(00)80971-8

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Recent analytical methods for cephalosporins in biological fluids.

Authors:  R D Toothaker; D S Wright; L A Pachla
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

Review 2.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

3.  Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.

Authors:  J G Gambertoglio; D P Alexander; S L Barriere
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

4.  Cefmenoxime pharmacokinetics in patients with renal insufficiency.

Authors:  R E Polk; D A Sica; T M Kerkering; B J Kline; P M Patterson; J W Baggett
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

5.  Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.

Authors:  D A Sica; R E Polk; T M Kerkering; P Patterson; J Baggett
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Microbiological efficacy and pharmacokinetics of prophylactic antibiotics in liver transplant patients.

Authors:  P M Arnow; K Furmaga; J P Flaherty; D George
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.